本文選題：無創(chuàng)產(chǎn)前檢測 + 指南��； 參考：《中國實用婦科與產(chǎn)科雜志》2017年06期

【摘要】：隨著二代測序技術(shù)在產(chǎn)前篩查臨床應(yīng)用的開展,國際上一些有影響力的學(xué)術(shù)組織相繼發(fā)表和不斷更新了關(guān)于該技術(shù)的應(yīng)用指南和共識。國家衛(wèi)生計生委組織專家總結(jié)我國的無創(chuàng)產(chǎn)前檢測(NIPT)試點工作經(jīng)驗,結(jié)合國際國內(nèi)的臨床研究成果制定了我國《孕婦外周血胎兒游離DNA產(chǎn)前篩查與診斷技術(shù)規(guī)范》。該技術(shù)規(guī)范主要包括開展孕婦外周血胎兒游離DNA產(chǎn)前篩查與診斷技術(shù)的基本要求、適用范圍、臨床服務(wù)流程、檢測技術(shù)流程以及質(zhì)量控制指標等內(nèi)容。為規(guī)范、有序地在我國開展該技術(shù)進行產(chǎn)前篩查和產(chǎn)前診斷提供了依據(jù)。
[Abstract]:With the development of the second generation sequencing technology in the clinical application of prenatal screening, some influential international academic organizations have published and updated the guidelines and consensus on the application of this technology one after another.The experts of the State Health and Family Planning Commission summarized the experience of non-invasive prenatal testing (NIPT) pilot work in our country, and formulated the Technical Standard of Prenatal screening and diagnosis of Fetal Free DNA in pregnant Women combined with the International and domestic Clinical Research results.The technical specification mainly includes the basic requirements of prenatal screening and diagnosis of fetal free DNA in maternal peripheral blood, the scope of application, the clinical service flow, the technical process of detection and the quality control index, and so on.It provides the basis for standard and orderly development of prenatal screening and prenatal diagnosis in China.
【作者單位】： 中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院北京協(xié)和醫(yī)院婦產(chǎn)科;
【分類號】：R440;R714.5

【相似文獻】

相關(guān)會議論文 前1條

1 王挺;李海波;文萍;李瓊;王瑋;李紅;;373例高危孕婦無創(chuàng)產(chǎn)前檢測結(jié)果分析[A];中華醫(yī)學(xué)會第十次全國婦產(chǎn)科學(xué)術(shù)會議產(chǎn)科會場（產(chǎn)科學(xué)組、妊高癥學(xué)組）論文匯編[C];2012年

，

本文編號：1768169